Pediatric Immunology

Building Your Care Team and Preparing for Visits

At a Glance

Children with ITK deficiency benefit from coordinated care at an experienced pediatric center involving immunology, transplant, hematology and oncology, and infectious disease specialists. Bring complete genetic, immune, infection, imaging, and medication records to each evaluation.

Building the right medical team is one of the most critical steps in managing ITK deficiency. Because this condition spans immunology, blood disorders, and complex genetics, your child needs a multidisciplinary “center of excellence” where specialists collaborate daily ^[1]^[2].

The Core Care Team

A comprehensive team for ITK deficiency ensures that every aspect of the disease—from the underlying genetic error to the risk of lymphoma—is monitored by an expert.

Pediatric Immunologist: The primary architect of your child’s care. They monitor immune cell counts, manage antibody replacements (IVIG), and track how well the immune system is (or isn’t) fighting viruses ^[1]^[3].
Pediatric Hematologist/Oncologist: These specialists focus on the blood and the risks of lymphoma or HLH. They are essential for managing any EBV-related cell growth or the “cytokine storms” associated with the condition ^[2]^[4].
Blood and Marrow Transplant (BMT) Specialist: Because HSCT is a potential cure, a pediatric transplant physician or team should be involved early. They evaluate donor options and design the “conditioning” plan to prepare your child’s body for new cells ^[5]^[6].
Infectious Disease (ID) Specialist: These experts manage the complex antimicrobial and antifungal medications needed to prevent “opportunistic” infections while the immune system is weak ^[2]^[5].
Supportive Specialists: This includes Genetics for family counseling, Radiology for interpreting scans of the liver and spleen, and Pathology for reviewing any tissue biopsies to check for EBV or lymphoma ^[2]^[3]^[7].

Preparing for the First Specialist Visit

The first visit to a specialized center is often a “deep dive” into your child’s history. To make the most of this time, you should arrive prepared to provide a complete picture of your child’s health journey ^[8]^[9].

The Records You Need

While hospitals can often transfer records directly, keeping track of them helps avoid delays.

Genetic Testing Reports: The full laboratory report showing the specific ITK mutations and, if available, results from parental “segregation” testing ^[9]^[10].
Immune Lab Trends: Every Flow Cytometry report (T-cell and iNKT counts), Quantitative Immunoglobulins (IgG/A/M), and Vaccine Titer results ^[8]^[9].
Infection and Viral Logs: A chronological record of EBV and CMV viral loads (PCR tests) and a list of every significant infection or hospitalization ^[11]^[12].
Pathology and Imaging: If your child has had a biopsy, arrange for the pathology slides and the actual imaging discs (in DICOM format) to be transferred so the center’s own specialists can review them directly ^[13]^[14].
Medication and Vaccine History: A complete list of all current medications, doses, and a record of every vaccine your child has ever received ^[8]^[5].

Identifying a “Center of Excellence”

Not every hospital has the infrastructure to manage ultra-rare immunodeficiencies. When choosing a center, look for these quality indicators:

Registry Participation: Many top centers report their data to international registries (like EBMT or CIBMTR) to benchmark their outcomes against other top centers ^[15].
Pediatric Transplant Accreditation: Look for centers with pediatric transplant accreditation, experience in inborn errors of immunity, and transparent outcomes ^[15].
Multidisciplinary Coordination: An experienced center will have robust, 24/7 emergency coverage where immunologists and transplant doctors work as a single unit, rather than in separate silos ^[16]^[6].
Advanced Laboratory Capabilities: The ability to access specialized T-cell signaling tests and “clean” donor grafts (like TCRαβ/CD19 depletion) either in-house or through specialized partnerships is often a sign of a high-volume, experienced center ^[17]^[18].

By assembling a team that understands the specific nuances of ITK deficiency, you ensure that your child is being monitored with the highest level of expertise available ^[5]^[19].

Common questions in this guide

Which specialists should care for a child with ITK deficiency?

Care commonly involves a pediatric immunologist, hematologist/oncologist, transplant specialist, and infectious disease specialist. Genetics, radiology, and pathology may also be involved so genetic results, scans, and biopsies are interpreted together.

What records should I bring to an ITK deficiency specialist visit?

Bring the full genetic testing report, immune lab trends, vaccine titers, EBV and CMV viral-load results, infection and hospitalization history, medication list, and vaccine history. If biopsies or imaging were done, ask whether pathology slides and DICOM imaging files can be sent for review.

Why should a transplant team be involved early in ITK deficiency?

Hematopoietic stem cell transplantation, or HSCT, may offer a potential cure, so early transplant consultation allows the team to review donor options and conditioning plans. It also helps coordinate care if EBV complications, HLH, or serious infections occur while a transplant is being considered.

How can I choose a center experienced in ITK deficiency?

Look for a pediatric center with experience in inborn errors of immunity, transplant accreditation, multidisciplinary coordination, and access to specialized immune testing and graft-processing techniques. Registry participation, such as EBMT or CIBMTR, and transparent transplant outcomes can provide additional information about the center’s experience.

What should I ask about EBV or HLH while waiting for a transplant?

Ask what the center’s emergency plan is for a rising EBV viral load or active hemophagocytic lymphohistiocytosis, also called HLH. Clarify which team leads urgent decisions and how immunology, hematology/oncology, infectious disease, and transplant specialists communicate.

How will long-term follow-up be handled after transplant?

Ask who will coordinate monitoring for graft-versus-host disease, or GvHD, late infections, and recovery of the immune system. The team should explain which specialists will follow your child, how often visits occur, and whom to contact between visits.

Get notified when new evidence is published on Combined immunodeficiency due to ITK deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (19)

1
Epstein-Barr virus-driven lymphoproliferation in inborn errors of immunity: a diagnostic and therapeutic challenge.
Barman P, Basu S, Goyal T, et al.
Expert review of clinical immunology 2024; (20(11)):1331-1346 doi:10.1080/1744666X.2024.2386427.
PMID: 39066572
2
Multidisciplinary approach to early identification of inborn errors of immunity in patients with lymphoproliferation.
Alsina L, Celis Passini V, Garrido Colino C, et al.
Leukemia & lymphoma 2026; (67(11)):2192-2205 doi:10.1080/10428194.2026.2704265.
PMID: 42518275
3
How to recognize inborn errors of immunity in a child presenting with a malignancy: guidelines for the pediatric hemato-oncologist.
Bosch JVWT, Hlaváčková E, Derpoorter C, et al.
Pediatric hematology and oncology 2023; (40(2)):131-146 doi:10.1080/08880018.2022.2085830.
PMID: 35913104
4
Management of XLP-1 and ITK deficiency: The challenges posed by PID with an unpredictable spectrum of disease manifestations.
Shadur B, Abuzaitoun O, NaserEddin A, et al.
Clinical immunology (Orlando, Fla.) 2019; (198()):39-45 doi:10.1016/j.clim.2018.12.016.
PMID: 30572125
5
Inborn Errors of Immunity and Hematopoietic Cell Transplantation: Recognition and Pretransplant Management.
Greenwell AM, Gupte A, Al-Antary ET
Pediatric annals 2026; (55(9)):e341-e349 doi:10.3928/19382359-20260628-02.
PMID: 42692989
6
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives.
Castagnoli R, Delmonte OM, Calzoni E, Notarangelo LD
Frontiers in pediatrics 2019; (7()):295 doi:10.3389/fped.2019.00295.
PMID: 31440487
7
Inborn Errors of Immunity in Pediatric Hematology and Oncology: Diagnostic Principles for Clinical Practice.
Roberti G, Maestrini G, Polito B, et al.
Journal of clinical medicine 2025; (14(17)) doi:10.3390/jcm14176295.
PMID: 40944054
8
Inborn Errors of Immunity.
Baloh CH, Chong H
Primary care 2023; (50(2)):253-268 doi:10.1016/j.pop.2022.12.001.
PMID: 37105605
9
Diagnostic tests for primary immunodeficiency disorders: Classic and genetic testing.
Klangkalya N, Fleisher TA, Rosenzweig SD
Allergy and asthma proceedings 2024; (45(5)):355-363 doi:10.2500/aap.2024.45.240051.
PMID: 39294902
10
A great disturbance in the force: IL-2 receptor defects disrupt immune homeostasis.
Hernandez JD, Hsieh EWY
Current opinion in pediatrics 2022; (34(6)):580-588 doi:10.1097/MOP.0000000000001181.
PMID: 36165614
11
Impact of cytomegalovirus infection prior to hematopoietic stem cell transplantation in children with inborn errors of immunity.
Del Rosal T, Quintana-Ortega C, Deyá-Martinez A, et al.
European journal of pediatrics 2022; (181(11)):3889-3898 doi:10.1007/s00431-022-04614-5.
PMID: 36102997
12
Primary immunodeficiency disease: a retrospective study of 112 Chinese children in a single tertiary care center.
Wu J, Zhong W, Yin Y, Zhang H
BMC pediatrics 2019; (19(1)):410 doi:10.1186/s12887-019-1729-7.
PMID: 31684895
13
Rubella-associated granuloma in a patient with a compound heterozygous RAG1 defect and review of the literature.
Akarsu A, Sonmez G, Schiefer AI, et al.
Immunologic research 2025; (73(1)):150 doi:10.1007/s12026-025-09711-9.
PMID: 41139764
14
Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG/NEMO mutations.
Miot C, Imai K, Imai C, et al.
Blood 2017; (130(12)):1456-1467 doi:10.1182/blood-2017-03-771600.
PMID: 28679735
15
Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019.
Duarte RF, Labopin M, Bader P, et al.
Bone marrow transplantation 2019; (54(10)):1525-1552 doi:10.1038/s41409-019-0516-2.
PMID: 30953028
16
How I use allogeneic HSCT for adults with inborn errors of immunity.
Burns SO, Morris EC
Blood 2021; (138(18)):1666-1676 doi:10.1182/blood.2020008187.
PMID: 34077952
17
Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity.
Lum SH, Albert MH, Gilbert P, et al.
Blood 2024; (144(5)):565-580 doi:10.1182/blood.2024024038.
PMID: 38669631
18
T-replete HLA-matched grafts vs T-depleted HLA-mismatched grafts in inborn errors of immunity.
Lum SH, Greener S, Perez-Heras I, et al.
Blood advances 2022; (6(4)):1319-1328 doi:10.1182/bloodadvances.2020004072.
PMID: 34972212
19
[Clinical and immunological evaluation of patients with inborn errors of immunity after hematopoietic cell transplantation].
Llarens A, Cabanillas D, Tejada MP, et al.
Archivos argentinos de pediatria 2026; (124(5)):e202611024 doi:10.5546/aap.2026-11024.
PMID: 42189513

This page is for informational purposes only and does not constitute medical advice. Your child’s immunology and transplant teams can advise you about records, treatment decisions, and urgent symptoms.